<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: BACKGROUND: Individuals with <z:mp ids='MP_0002055'>diabetes</z:mp> who are smokers have higher risks of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, premature <z:hpo ids='HP_0011420'>death</z:hpo>, and microvascular complications </plain></SENT>
<SENT sid="1" pm="."><plain>The present study aims to determine the prevalence of symptoms of <z:hpo ids='HP_0000716'>depression</z:hpo> and <z:hpo ids='HP_0000739'>anxiety</z:hpo> in smokers with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2D) and to evaluate if the prevalence of symptoms of <z:hpo ids='HP_0000716'>depression</z:hpo> and <z:hpo ids='HP_0000739'>anxiety</z:hpo> differ between the three groups studied (patients with T2D who smoke; patients with T2D who do not smoke; smokers without T2D), and finally determine if the degree of <z:chebi fb="164" ids="18723">nicotine</z:chebi> dependence is related to symptoms of <z:hpo ids='HP_0000739'>anxiety</z:hpo> and <z:hpo ids='HP_0000716'>depression</z:hpo> in smokers (with or without T2D) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Three study groups were formed: 46 T2D smokers (DS), 46 T2D non-smokers (D), and 46 smokers without <z:mp ids='MP_0002055'>diabetes</z:mp> (S), totaling 138 participants </plain></SENT>
<SENT sid="3" pm="."><plain>Hospital <z:hpo ids='HP_0000739'>Anxiety</z:hpo> and <z:hpo ids='HP_0000716'>Depression</z:hpo> (HAD) scale and Fagerström Test were applied </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The prevalence of symptoms of <z:hpo ids='HP_0000716'>depression</z:hpo> and <z:hpo ids='HP_0000739'>anxiety</z:hpo> in smokers with T2D was 30.4% and 50%, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>There was no significant difference in the proportion of individuals with symptoms of <z:hpo ids='HP_0000739'>anxiety</z:hpo> (p = 0.072) or <z:hpo ids='HP_0000716'>depression</z:hpo> (p = 0.657) in the DS group compared to group D or S </plain></SENT>
<SENT sid="6" pm="."><plain>Among male patients with T2D, the smokers had a higher prevalence of <z:hpo ids='HP_0000739'>anxiety</z:hpo> symptoms (19.6%) than non-smokers (4,3%) (p = 0,025) </plain></SENT>
<SENT sid="7" pm="."><plain>The prevalence of high <z:chebi fb="164" ids="18723">nicotine</z:chebi> dependence among smokers with and without T2D was 39.1% and 37.1%, respectively (p = 0.999) </plain></SENT>
<SENT sid="8" pm="."><plain>Fagerström scores showed no significant correlation with the scores obtained on the subscale of <z:hpo ids='HP_0000739'>anxiety</z:hpo> (p = 0,735) or <z:hpo ids='HP_0000716'>depression</z:hpo> (p = 0,364) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The prevalence of <z:hpo ids='HP_0000716'>depression</z:hpo> and <z:hpo ids='HP_0000739'>anxiety</z:hpo> among smokers with and without <z:mp ids='MP_0002055'>diabetes</z:mp> and non-smokers T2D is similar </plain></SENT>
<SENT sid="10" pm="."><plain>Among male individuals with T2D, the smokers have more symptoms of <z:hpo ids='HP_0000739'>anxiety</z:hpo> than the non-smokers </plain></SENT>
<SENT sid="11" pm="."><plain>There is no difference in the prevalence of <z:chebi fb="164" ids="18723">nicotine</z:chebi> dependence among smokers with and without <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>The presence of symptoms of <z:hpo ids='HP_0000739'>anxiety</z:hpo> or <z:hpo ids='HP_0000716'>depression</z:hpo> is similar between patients who are dependent and not dependent on <z:chebi fb="164" ids="18723">nicotine</z:chebi> </plain></SENT>
</text></document>